Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease ...
6d
Arcturus Therapeutics Spotlights Inhaled mRNA CF Phase 2b Plan, FDA Talks for OTC Program at Summit
Arcturus Therapeutics (NASDAQ:ARCT) used a presentation at Guggenheim’s 2026 Emerging Outlook Biotech Summit to highlight ...
Arcturus Therapeutics now centers on ARCT-032 (cystic fibrosis) and ARCT-810 (OTC deficiency), with Covid assets as secondary ...
Women walk past a coronavirus (COVID-19) themed mural on a street in Mumbai, India, March 28, 2023. REUTERS/Francis Mascarenhas A new coronavirus subvariant, XBB. 1.16, has been designated as a ...
A new COVID variant Arcturus has caused a huge uptick in infections in India. (Reuters) Five people in England have died from the new COVID variant dubbed Arcturus, the UK Health Security Agency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results